ResearcherEast China Normal UniversityActive in the last 2 years

Wenzheng Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4999-4168; OpenAlex author ID A5054017032, A5125745009. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

TIPE2 knockdown enhances the anti-tumor efficacy of NKG2D CAR-T cells against pancreatic cancer via activating NF-κb signaling pathway. Last author DOI 10.1186/s12967-026-07831-w ↗
Co-expression of IL-15/IL-15Ra complex enhances NKG2D-CAR T cell-mediated anti-pancreatic cancer immunity by activating the JAK/STAT5 signaling pathway. Last author DOI 10.3389/fimmu.2025.1498706 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Muhammad Asad Farooq · 1 shared paper, 2026 · strength 0.39
- Paper TIPE2 knockdown enhances the anti-tumor efficacy of NKG2D CAR-T cells against pancreatic cancer via activating NF-κb si… DOI 10.1186/s12967-026-07831-w ↗
Yiran Chen · 1 shared paper, 2025 · strength 0.23
- Paper Co-expression of IL-15/IL-15Ra complex enhances NKG2D-CAR T cell-mediated anti-pancreatic cancer immunity by activating… DOI 10.3389/fimmu.2025.1498706 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.